AEAhmed S. Elwehidy

Ahmed S. Elwehidy

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Ahmed S. Elwehidy has a total of 35 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Two-Year Outcomes of Visco-Circumferential Suture Trabeculotomy vs. Rigid Probe Hemi-Trabeculotomy in Late-Onset Primary Congenital Glaucoma

    by Ahmed S. Elwehidy, Mostafa A. Elwehidy, Rasha M. Elzeini, Mohammed Elashry, Ghada H. Allam, Mostafa Damlakhi, Abdelrahman M. Elhusseiny

  • The effect of treatment of primary congenital glaucoma on meibomian glands and tear film

    by Ahmed S. Elwehidy, Dina Abd Elfattah, Aya M. Hashish, Muhammad Z. Chauhan, Hajirah N. Saeed, Abdelrahman M. Elhusseiny

    Purpose To evaluate meibomian gland (MG) and tear film alterations in treated primary congenital glaucoma (PCG) patients through a comparative study. Methods We conducted a comparative, cross-sectional study analysing eyes with treated PCG vs healthy eyes of age-matched children using the MediWorks Dry Eye Diagnostic System to perform a non-contact quantitative analysis. Seven ocular parameters were measured: non-invasive break-up time (NIBUT), tear meniscus height, lipid layer thickness, eyelid edge morphology, MG morphology, ocular surface staining, and conjunctival hyperaemia. Results Our study included 71 treated PCG eyes (42 patients) and 30 non-glaucomatous healthy eyes (30 patients). Thirty (21 patients) of the 71 treated PCG eyes (42.3%) were on topical glaucoma medications at the time of study enrolment. MG loss grade (1.3 ± 0.5 vs 0.1 ± 0.3, P < 0.001), mean first rupture NIBUT (7.2 ± 2.6 s vs 11.9 ± 2.4 s, P < 0.001), lipid layer grade (3.2 ± 0.6 vs 3.6 ± 0.5, P = 0.03), and prevalence of low tear meniscus height (46.5% vs 93.3%, P < 0.001) were all significantly altered in the treated PCG group as compared to healthy controls. Sub-group analyses revealed significantly worse MG and tear film parameters in treated PCG eyes on glaucoma medications vs treated PCG eyes not on glaucoma medications and treated PCG eyes not on glaucoma medications vs healthy controls. Glaucoma surgery was also associated with worse parameters. Conclusion In this first study to evaluate MG and tear film parameters in treated PCG, significant differences were observed in the MG morphology and tear film parameters of eyes with treated PCG compared to the eyes of healthy children. Glaucoma medication use and glaucoma surgery were individually correlated with ocular surface disease in treated PCG.


  • Open Access

    Predictability of Optical Coherence Tomography Parameters in Preperimetric Glaucoma

    by Dalia Sabry, Ahmed S Elwehidy, Ameera Gamal Abdelhameed, Ehab Tharwat, Amr M Abdelkader

  • Five-year results of viscotrabeculotomy versus conventional trabeculotomy in primary congenital glaucoma: A randomized controlled study

    by Ahmed S Elwehidy, Sherein M Hagras, Nader Bayoumi, Ayman E AbdelGhafar, Amani E Badawi

    Purpose: To assess the long-term results of viscotrabeculotomy in infants with primary congenital glaucoma and to compare its outcome with conventional trabeculotomy. Patients and methods: A prospective randomized comparative study included infants with primary congenital glaucoma younger than 2 years. Patients were divided into two groups: viscotrabeculotomy group and conventional trabeculotomy group. Preoperative and postoperative intraocular pressures, corneal diameter, intraoperative and postoperative complications, and success rates were compared between two groups. All the patients were followed up for 5 years. Results: The study included 154 eyes of 92 infants distributed randomly among the two groups; 78 and 76 eyes in viscotrabeculotomy and conventional trabeculotomy groups, respectively. In both groups, there was a statistically significant intraocular pressure reduction at all time points of the follow-up periods compared to the preoperative values (p < 0.0001). At 5 years, viscotrabeculotomy group showed significant reduction of the mean postoperative intraocular pressure (49.47%) than conventional trabeculotomy group (48.64%) (p < 0.0001). Intraocular pressure was statistically lower in viscotrabeculotomy starting from 12th month and till the end of the follow-up. At 5 years, the total success rate of viscotrabeculotomy group was 89.74% compared to 85.53% in conventional trabeculotomy group without significant difference (p = 0.487). The postoperative mean values of the cup/disk ratio in viscotrabeculotomy group showed statistically lower values compared to conventional trabeculotomy group (p = 0.019). Postoperative hyphema was statistically higher in conventional trabeculotomy group (p < 0.0001). All eyes that underwent a reoperation before 5 years follow-up were excluded from the statistical workup of the study after reoperation, except for calculation of success/failure. Conclusion: Viscotrabeculotomy and conventional trabeculotomy proved to be effective in cases of primary congenital glaucoma. Viscotrabeculotomy appeared to have prolonged stability in controlling the intraocular pressure with higher success rates and lower complications.


  • Combined phacoemulsification-viscosynechialysis-trabeculotomy vs phacotrabeculectomy in uncontrolled primary angle-closure glaucoma with cataract

    by Ahmed S. Elwehidy, Nader H.L. Bayoumi, Amani E. Badawi, Sherein M. Hagras, Rania Kamel

    To compare the effect on intraocular pressure (IOP) of phacoemulsification combined with viscosynechialysis and trabeculotomy with that of phacoemulsification combined with trabeculectomy in eyes with primary angle-closure glaucoma (PACG) and visually significant cataract. Mansoura Ophthalmic Center, Mansoura University, Egypt. Prospective case series. This prospective randomized study included patients with uncontrolled PACG and visually significant cataract presenting between 2012 and 2017. The eyes were randomized to phacoemulsification combined with viscosynechialysis and trabeculotomy (phaco–viscosynechialysis group) or phacoemulsification combined with trabeculectomy (phacotrabeculectomy group). Success (true and qualified) (IOP P = .704). The mean preoperative IOP was 28.7 ± 2.14 mm Hg in the phaco–viscosynechialysis group and 28.5 ± 2.11 mm Hg in the phacotrabeculectomy group; the mean at 24 months was 14.5 ± 2.8 mm Hg and 17.3 ± 2.2 mm Hg, respectively (P < .001). The total success rate at 24 months was 90% and 83%, respectively. Although both techniques were relatively safe and effective in reducing IOP for at least 2 years in eyes with PACG, combined phacoemulsification–viscosynechialysis–trabeculotomy gave better outcomes.


  • Open Access

    Intravitreal Ranibizumab With Panretinal Photocoagulation Followed by Trabeculectomy Versus Visco-Trabeculotomy in Management of Neovascular Glaucoma

    by Ahmed S. Elwehidy, Nader Hussein Lotfy Bayoumi, Amani E. Badawi, Sherein M. Hagras, Amr Abdelkader


  • Ahmed Glaucoma Valve Revision Versus Visco-Trabeculotomy After Failed Ahmed Glaucoma Valve in Refractory Pediatric Glaucoma

    by Ahmed S. Elwehidy, Amani E. Badawi, Sherein M. Hagras, Nader H.L. Bayoumi

    Purpose: To compare the outcome of the intraocular pressure (IOP) of Ahmed glaucoma valve (AGV) revision to visco-trabeculotomy (VT) in children’s eyes with failed AGV. Patients and Methods: A prospective randomized study conducted on 41 children (41 eyes) with uncontrolled glaucoma with an AGV presenting to the pediatric ophthalmology clinic of Mansoura Ophthalmic Center between 2011 and 2016. Study eyes were randomized to AGV revision or VT. Success (true and qualified) (IOPP=0.654). The most common glaucoma type was primary congenital glaucoma in both groups. The mean±SD of the duration between the last glaucoma procedure and the current study intervention was 24.9±4.8 and 25.2±5.8 months in the AGV revision and VT groups, respectively. The mean±SD preoperative IOP and at 12-month follow-up was 32.1±3.2 and 23.2±3.5 mm Hg in the AGV revision group and was 33.3±2.2 and 20.0±3.5 mm Hg in the VT group. The total success rates at 12 months were 31.6% and 63.7% in the AGV revision and VT groups, respectively. Conclusions: Both VT and AGV revision are reasonably successful and safe interventions for refractory childhood glaucoma after the failure of an AGV. VT is significantly better than AGV revision, resulting in higher success rates and a decrease in IOP-lowering medication use.


  • Open Access

    Two-stage procedure in the management of selected cases of keratoconus: clear lens extraction with aspherical IOL implantation followed by WFG-PRK

    by Waleed Abou Samra, Tharwat Mokbel, Mohammed Elwan, Sameh Saleh, Ahmed Elwehidy, Mohammed Iqbal, Adel Ellayeh

    AIM: To assess the objective and subjective results of a two-stage procedure for management of keratoconus: clear lensectomy with aspherical intraocular lens (IOL) implantation followed by wave front-guided photorefractive keratotomy (WFG-PRK). METHODS: This prospective interventional non-randomized study included patients aged 35 years old or more with grade I and II stable keratoconus, a clear visual axis, minimal corneal thickness (MCT) 420 mu m or more and average keratometric reading (K) less than 54 diopter (D). Refraction of all selected eyes should be -8.00 D sphere or more with less than -6.00 D cylinder and could be corrected two lines or more with spectacles or contact lenses. All studied eyes underwent a two-stage approach treatment: first refractive lens exchange and aspherical IOL implantation followed, after at least 3mo, by WFGPRK. Pre and postoperative complete ophthalmological examination were performed. Topographical, visual and aberrometric results were recorded and evaluated during 6mo follow up period. Moreover, patient satisfaction and other subjective outcomes were also analyzed. RESULTS: The 13 eyes of 11 patients diagnosed with stable keratoconus and aged from 39 to 49y (42.4 +/- 6.2y) were enrolled in the study. At baseline, 8 eyes had grade I and 5 eyes had grade II keratoconus. The manifest sphere was -10.3 +/- 4.2 D (ranged from -8.0 to -14.0 D) and the manifest cylinder was -4.2 +/- 1.2 D (ranged from -1.75 to -5.50 D). After the two-stage procedure, sphere and cylinder reduced significantly to -0.43 +/- 0.22 D and -1.3 +/- 0.72 D respectively (P<0.001). There was also a highly significant improvement in the mean uncorrected distance visual acuity (UDVA) from logMAR 1.41 +/- 0.49 preoperatively to 0.51 +/- 0.16 postoperatively (P<0.001) and the mean corrected distance visual acuity (CDVA) from 0.76 +/- 0.24 preoperatively to 0.49 +/- 0.13 after the operation (P<0.001). All aberrometric and mesopic vision parameters and most of the topographical indices demonstrated highly significant improvement that remains stable until the end of follow up. All recorded subjective data revealed a high degree of patient satisfaction. CONCLUSION: Two-stage approach (clear lens exchange with monofocal IOL followed by WFG-PRK) in selected cases of keratoconus is a safe, effective and highly predictable procedure with satisfactory visual and refractive results.


  • Open Access

    Intravitreal bevacizumab (avastin) as an adjuvant treatment in cases of neovascular glaucoma

    by AsaadA Ghanem, Amr M El- Kannishy, Ahmed S El- Wehidy, Amira F El-Agamy

    Purpose: To evaluate the effect of intravitreal bevacizumab (avastin) injection in cases of neovascular glaucoma. Study Design: Clinical case series. Materials and Methods: Sixteen eyes of 16 patients with rubeosis iridis and secondary glaucoma were administered intravitreal injection of bevacizumab (2.5 mg). The patients were followed for 2 months. Results: We noted partial or complete regression of iris neovascularization 1 week after injection of bevacizumab. Reproliferation of new vessels was detected in 25% of the cases after 2 months. The mean intraocular pressure (IOP) before injection was 28? 9.3 mm Hg under topical β-blocker and systemic acetazolamide. One week after injection, the IOP decreased to 21.7? 11.5 mm Hg (5 cases without anti-glaucoma drugs, 6 cases with topical β-blocker and 5 cases with both topical β-blocker and systemic acetazolamide). Conclusion: Intravitreal bevacizumab (avastin) injection leads to regression of iris neovascularization with subsequent drop of IOP in eyes with neovascular glaucoma.